Skip to content
Open access · OA via Europe PMC

Considerations for therapeutic targets for clinical trials in biomarker-characterized prodromal Parkinson's disease populations

Schneider R, Skibinski G, Fiske B, Kopil C, Merchant K, Simuni T.

Journal of Parkinson's disease : Duplicate, marked for deletion · 2026

Abstract

This article discusses potential therapeutic targets for clinical trials involving biomarker-characterized populations with prodromal Parkinson's disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
Canonical
link ↗
Fetched
2026-10-11 MST

Cite this

APA
R, S., G, S., B, F., C, K., K, M., &amp; T., S. (2026). Considerations for therapeutic targets for clinical trials in biomarker-characterized prodromal Parkinson's disease populations. <em>Journal of Parkinson's disease : Duplicate, marked for deletion</em>. https://europepmc.org/article/PMC/PMC13650051
Vancouver
R S, G S, B F, C K, K M, T. S. Considerations for therapeutic targets for clinical trials in biomarker-characterized prodromal Parkinson's disease populations. Journal of Parkinson's disease : Duplicate, marked for deletion. 2026.
BibTeX
@article{schneider2026Consid, title = {Considerations for therapeutic targets for clinical trials in biomarker-characterized prodromal Parkinson's disease populations}, author = {Schneider R and Skibinski G and Fiske B and Kopil C and Merchant K and Simuni T.}, journal = {Journal of Parkinson's disease : Duplicate, marked for deletion}, year = {2026}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings